+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Social Cognition in Psychosis

  • Book

  • April 2019
  • Elsevier Science and Technology
  • ID: 4759451

Social Cognition in Psychosis combines current research on phenotypes, neurobiology, and existing evidence on the assessment and treatment of various forms of psychoses. The book presents various treatment options, including assessment approaches, tools and training methods that aid in the rehabilitation of patients with psychotic disorders. Social cognition is a set of psychological processes related to understanding, recognizing, processing and appropriately using social stimuli in one's environment. Individuals with psychotic disorders consistently exhibit impairments in social cognition. As a result, social cognition has been an important target for intervention, with recent efforts trying to enhance early recovery among individuals with psychotic disorders.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Characterization of social cognitive deficits on the schizophrenia-bipolar disorder spectrum: An overview of current evidence 2. Cognitive and social cognitive deficits in paranoia 3. Social cognition and schizotypy 4. Impact of social cognitive deficits on community functioning 5. Shared neural substrates of deficits in social cognition and negative symptoms in schizophrenia 6. Role of oxytocin in social cognition in psychosis spectrum disorders 7. Reward processing and social functioning in psychosis 8. Substance misuse and social cognition on the psychosis-spectrum: A bottom-up framework 9. Assessment of social cognition 10. Improving ecological validity in research on social cognition 11. Social cognitive interventions 12. Psychosocial interventions for social dysfunction in psychosis

Authors

Kathryn Eve Lewandowski Schizophrenia and Bipolar Disorder Program, McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA. Dr. Eve Lewandowski is an assistant professor in Psychiatry at Harvard Medical School and Director of Clinical Programming for McLean OnTrack first episode clinic. Eve received her PhD in clinical psychology from the University of North Carolina, Greensboro, where she studied cognitive, behavioral, and genetic markers of schizotypy. She completed her postdoctoral fellowship at McLean Hospital/Harvard Medical School prior to joining the faculty. Her program of research centers on cognition and cognitive interventions for people with psychotic disorders. Her federally-funded research has included efficacy and neurobiological outcomes of cognitive remediation in bipolar disorder, computational approaches to characterizing heterogeneity in cognition across the psychoses, and examination of the latent structure of motivation and reward. She is currently conducting implementation work to translate cognitive remediation into clinical practice, for which she was awarded the 2018 Connie Lieber Science to Practice Award. Eve serves as the Director of the Psychology Doctoral Internship Program Psychotic Disorders training, and provides supervision, training, and mentorship to junior faculty, fellows, residents, and interns. Ahmed A. Moustafa School of Psychology, Faculty of Society and Design, Bond University, Gold Coast, Queensland, Australia.. Dr. Ahmed Moustafa is a Professor of Psychology and Computational Modeling at School of Psychology, Bond University, Gold Coast, Queensland, Australia. Prior to moving to Bond University, Ahmed was an associate professor in Psychology and Neuroscience at Marcs Institute for Brain, Behavior, and Development & School of Psychology, Western Sydney University. Ahmed is trained in computer science, psychology, neuroscience, and cognitive science. His early training took place at Cairo University in mathematics and computer science. Before joining Western Sydney University as a lab director, Ahmed spent 11 years in America working on several psychology and neuroscience projects. Ahmed conducts research on computational and neuropsychological studies of addiction, schizophrenia, Parkinson's disease, PTSD, depression, Alzheimer's disease. He has published over 240 papers in high-ranking journals including Science, PNAS, Journal of Neuroscience, Brain, Neuroscience and Biobehavioral Reviews, Nature (Parkinson's disease), Neuron, among others. Ahmed has obtained grant funding from Australia, USA, Qatar, UAE, Turkey, and other countries. Ahmed has recently published ten books: (1) Computational models of brain and behavior; (2) Social Cognition in Psychosis, (3) computational Neuroscience Models of the Basal Ganglia, (4) Cognitive, Clinical, and Neural Aspects of Drug Addiction; (5) The Nature of Depression: An updated review; (6) Big data in psychiatry and neurology; (7) Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy. Elsevier; (8) Cognitive and Behavioral Dysfunction in Schizophrenia; (9) Female Pioneers from Ancient Egypt and the Middle East; and (10) Mental health effects of COVID-19. In the last 10 years, Ahmed has published collaboratively with 71 colleagues, has more than 510 co-authors, from 35 institutions in 14 countries. Ahmed is now Editor-in-Chief of Discover Psychology, a new journal by Springer Nature.